163 related articles for article (PubMed ID: 31303376)
1. Evolution of pelvic exenteration surgery- resectional trends and survival outcomes over three decades.
Waters PS; Peacock O; Warrier SK; Wakeman C; Eglinton T; Lynch AC; Frizelle FA; Heriot AG; McCormick J
Eur J Surg Oncol; 2019 Dec; 45(12):2325-2333. PubMed ID: 31303376
[TBL] [Abstract][Full Text] [Related]
2. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
3. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
[TBL] [Abstract][Full Text] [Related]
4. Determinants of survival following pelvic exenteration for primary rectal cancer.
Radwan RW; Jones HG; Rawat N; Davies M; Evans MD; Harris DA; Beynon J;
Br J Surg; 2015 Sep; 102(10):1278-84. PubMed ID: 26095525
[TBL] [Abstract][Full Text] [Related]
5. Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.
Donati OF; Lakhman Y; Sala E; Burger IA; Vargas HA; Goldman DA; Andikyan V; Park KJ; Chi DS; Hricak H
Eur Radiol; 2013 Oct; 23(10):2906-15. PubMed ID: 23652852
[TBL] [Abstract][Full Text] [Related]
6. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
7. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
Katory M; McLean R; Paez E; Kucukmetin A; Naik R
Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
[TBL] [Abstract][Full Text] [Related]
8. Laparoscopic assessment improves case selection for exenterative surgery in recurrent cervical and endometrial cancer.
Heath OM; Bryan SJ; Sohaib A; Barton DPJ
J Obstet Gynaecol; 2021 Nov; 41(8):1252-1256. PubMed ID: 33646894
[TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
[TBL] [Abstract][Full Text] [Related]
10. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer.
Harris CA; Solomon MJ; Heriot AG; Sagar PM; Tekkis PP; Dixon L; Pascoe R; Dobbs BR; Frampton CM; Harji DP; Kontovounisios C; Austin KK; Koh CE; Lee PJ; Lynch AC; Warrier SK; Frizelle FA
Ann Surg; 2016 Aug; 264(2):323-9. PubMed ID: 26692078
[TBL] [Abstract][Full Text] [Related]
11. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
PelvEx Collaborative
BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of outcomes following pelvic exenteration for the treatment of primary and recurrent locally advanced rectal cancer.
Platt E; Dovell G; Smolarek S
Tech Coloproctol; 2018 Nov; 22(11):835-845. PubMed ID: 30506497
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of pelvic exenteration for recurrent and primary locally advanced rectal cancer.
Rottoli M; Vallicelli C; Boschi L; Poggioli G
Int J Surg; 2017 Dec; 48():69-73. PubMed ID: 28987560
[TBL] [Abstract][Full Text] [Related]
14. Pushing the boundaries of pelvic exenteration by maintaining survival at the cost of morbidity.
Venchiarutti RL; Solomon MJ; Koh CE; Young JM; Steffens D
Br J Surg; 2019 Sep; 106(10):1393-1403. PubMed ID: 31282571
[TBL] [Abstract][Full Text] [Related]
15. Pelvic exenteration for primary and recurrent gynaecological malignancies.
de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
[TBL] [Abstract][Full Text] [Related]
16. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
[TBL] [Abstract][Full Text] [Related]
17. Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer.
Jimenez RE; Shoup M; Cohen AM; Paty PB; Guillem J; Wong WD
Dis Colon Rectum; 2003 Dec; 46(12):1619-25. PubMed ID: 14668586
[TBL] [Abstract][Full Text] [Related]
18. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
19. Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group.
Nguyen DQ; McGregor AD; Freites O; Carr ND; Beynon J; El-Sharkawi AM; Lucas MG
Eur J Surg Oncol; 2005 Dec; 31(10):1180-4. PubMed ID: 16126362
[TBL] [Abstract][Full Text] [Related]
20. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer?
Rombouts AJ; Koh CE; Young JM; Masya L; Roberts R; De-Loyde K; de Wilt JH; Solomon MJ
Dis Colon Rectum; 2015 Jan; 58(1):65-73. PubMed ID: 25489696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]